Bilateral male breast cancer and prostate cancer: A case report

Japanese Journal of Clinical Oncology

Volumn 30, Issue 4, 2000, Pages 188-190

  Özet, Ahmet ^a   Yavuz, Ali Aydin ^a   Kömürcü, Seref ^a   Öztürk, Bekir ^a   Safali, Mükerrem ^a   Arpaci, Fikret ^a   Çaliskaner, Zafer ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Breast cancer; Multiple primary tumors; Prostate cancer

Indexed keywords

MEDROXYPROGESTERONE ACETATE; PACLITAXEL; TAMOXIFEN;

AGED; ARTICLE; ARTIFICIAL EMBOLISM; BREAST CARCINOMA; CANCER RECURRENCE; CASE REPORT; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; MALE; METASTASIS; PROSTATE CARCINOMA; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0034115427     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyd050     Document Type: Article

References (21)

1. Rizk SN, Assimacopoulos CA, Ryan JJ. Male breast cancer: three case reports and review of the literature. S D J Med 1994;47:343-6.
2. Bounds WE, Burton GV, Schwalke MA. Male breast cancer. J La State Med Soc 1993;145:353-6.
3. Hecht JR, Winchester DJ. Male breast cancer. Am J Clin Pathol 1994;102:25-30.
4. Cutuli BF, Lacroze M, Dilhuydy JM, Florentz P, Velten M, Allavena C, et al. Breast cancer in men: incidence and types of associated previous synchronous and metachronous cancers. Bull Cancer 1992;79:689-96.
5. DeAntoni EP, Crawford ED. Pretreatment of metastatic disease. Prostate cancer in the older male. Cancer 1994;74:2182-7.
6. Wilding G. Endocrine control of prostate cancer. Cancer Surv 1995;23:43-62.
7. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993;146:1305.
8. Pienta KJ, Goodson JA, Esper PS. Epidemiology of prostate cancer: molecular and environmental clues. Urology 1996;48:676-83.
9. Engin K. Cancers in multiple primary sites. Int Surg 1994;79:33-7.
10. Tajika M, Tuchiya T, Yasuda M, Ito Y, Nakamura T, Yamauchi K, et al. A male case of synchronous double cancers of the breast and prostate. Intern Med 1994;33:31-5.
11. Akashi-Tanaka S, Fukutomi T, Fukami A, Fujiki T. Male breast cancer in patients with a familial history of breast cancer. Surg Today 1996;26:975-9.
12. Tulinius H, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Bjarnadottir K. Neoplastic diseases in families of breast cancer patients. J Med Genet 1994;31:618-21.
13. Anderson DE, Badzioch MD. Familial effects of prostate and other cancers on lifetime breast cancer risk. Breast Cancer Res Treat 1993;28:107-13.
14. Stephens RL, Schimke RN. Case report: breast cancer in males - a genetic consideration. Am J Med Sci 1992;304:91-2.
15. MacLean HE, Wame GL, Zajac JD. Defects of androgen receptor function: from sex reversal to motor neurone disease. Mol Cell Endocrinol 1995;112:133-41.
16. Namer M, Cutuli BF, Pujol H, Sultan C. Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 1993;2:1799-802.
17. Chuaqui RF, Sanz Ortega J, Vocke C, Linehan WM, Sanz Esponera J, Zhuang Z, et al. Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas. Cancer Res 1995;55:4995-8.
18. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nature Genet 1996,13:117-9.
19. Tonin P, Ghadirian P, Phelan C, Lenoir GM, Lynch HT, Letendre F, et al. A large multisite cancer family is linked to BRCA2. J Med Genet 1995;32:982-4.
20. Bhargava V, Kell DL, Van de Rijn M, Wamke RA. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 1994;145:535-40.
21. Ross JS, Sheehan CE, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman RP Jr, et al. Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma Cancer 1997;79:2162-70.